Schedule 13G ownership disclosure
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Security class unavailable · CUSIP: 539319103
Event date: 2020-11-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.3800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-20-023777
- Form type
- SC 13G
- Filer
- FORMAN ERIC
- CIK
- CIK 1650389
- Filed
- Dec 17, 2020
- Reporting period
- Nov 30, 2020
- Description
- Schedule 13G beneficial ownership